FDA Inspection
Dayan K. Gandhi, M.D.Dayan K. Gandhi, M.D. – FDA Inspection, Jul 2, 2026
Record Details
This FDA Inspection record concerns Dayan K. Gandhi, M.D., with an inspection on July 2, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 5a4ac2bd-fb08-46a9-98ae-0524106106eb
Inspection Facts
- Inspection number
- 1325542
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.64(b)Safety Reports - Serious Events
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.